ArticleCureus2025
Minimally Invasive Approach to Intrauterine Device Migration Into the Bladder Using Holmium Laser.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The intrauterine device (IUD) is a widely utilized method of contraception known for its high efficacy, safety profile, and long-term effectiveness. Despite its favorable characteristics, rare but potentially serious complications may occur, such as uterine perforation and device migration into adjacent pelvic or abdominal structures. One of the less frequent but clinically relevant complications is intravesical migration, where the device perforates the uterine wall and erodes into the urinary bladder. This can result in chronic lower urinary tract symptoms, recurrent urinary tract infections, hematuria, pelvic discomfort, and, in some cases, stone formation around the foreign body. We present the case of a 26-year-old female patient who developed recurrent urinary symptoms and intermittent hematuria three years after IUD placement. The device had not been visualized during gynecological follow-up and remained undetected during two full-term pregnancies. A noncontrast abdominal CT scan ultimately revealed a calcified IUD located within the urinary bladder. The patient underwent successful transurethral endoscopic removal using holmium:YAG laser lithotripsy in dusting mode to fragment the calcifications, followed by retrieval of the intact device with foreign body forceps. The procedure was completed without complications, and the patient reported full resolution of symptoms during follow-up. This case underscores the importance of considering IUD migration as a differential diagnosis in women presenting with unexplained urinary symptoms and a remote history of IUD use. It also demonstrates that holmium laser-assisted endoscopic management provides a safe, effective, and minimally invasive approach to remove encrusted or calcified intravesical IUDs, avoiding the need for open or laparoscopic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.